Erypro (recombinant human erythropoietin alpha)
/ Biocon
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 13, 2022
The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®
(clinicaltrials.gov)
- P=N/A | N=82 | Completed | Sponsor: PT. Daewoong Infion
New trial • Chronic Kidney Disease • Nephrology • Renal Disease
1 to 1
Of
1
Go to page
1